BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 31727782)

  • 1. The role of interleukin-17 in tumor development and progression.
    Zhao J; Chen X; Herjan T; Li X
    J Exp Med; 2020 Jan; 217(1):. PubMed ID: 31727782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological Approaches Towards Cancer and Inflammation: A Cross Talk.
    Qu X; Tang Y; Hua S
    Front Immunol; 2018; 9():563. PubMed ID: 29662489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The IL-23/IL-17 pathway in inflammatory bowel disease.
    Geremia A; Jewell DP
    Expert Rev Gastroenterol Hepatol; 2012 Apr; 6(2):223-37. PubMed ID: 22375527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene of the month: Interleukin 6 (IL-6).
    Ataie-Kachoie P; Pourgholami MH; Richardson DR; Morris DL
    J Clin Pathol; 2014 Nov; 67(11):932-7. PubMed ID: 25031389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Interleukin-17 in Lung Cancer.
    Wu F; Xu J; Huang Q; Han J; Duan L; Fan J; Lv Z; Guo M; Hu G; Chen L; Zhang S; Tao X; Ma W; Jin Y
    Mediators Inflamm; 2016; 2016():8494079. PubMed ID: 27872514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proinflammatory signaling functions of thrombin in cancer.
    Ebrahimi S; Rahmani F; Behnam-Rassouli R; Hoseinkhani F; Parizadeh MR; Keramati MR; Khazaie M; Avan A; Hassanian SM
    J Cell Physiol; 2017 Sep; 232(9):2323-2329. PubMed ID: 28004386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into the role of IL-32 in cancer.
    Sloot YJE; Smit JW; Joosten LAB; Netea-Maier RT
    Semin Immunol; 2018 Aug; 38():24-32. PubMed ID: 29747940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wounds that heal and wounds that don't - The role of the IL-33/ST2 pathway in tissue repair and tumorigenesis.
    Millar NL; O'Donnell C; McInnes IB; Brint E
    Semin Cell Dev Biol; 2017 Jan; 61():41-50. PubMed ID: 27521518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human colon carcinogenesis is associated with increased interleukin-17-driven inflammatory responses.
    Xie Z; Qu Y; Leng Y; Sun W; Ma S; Wei J; Hu J; Zhang X
    Drug Des Devel Ther; 2015; 9():1679-89. PubMed ID: 25834404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation, cytokines, the IL-17/IL-6/STAT3/NF-κB axis, and tumorigenesis.
    Chen XW; Zhou SF
    Drug Des Devel Ther; 2015; 9():2941-6. PubMed ID: 26089643
    [No Abstract]   [Full Text] [Related]  

  • 11. Th17 Cells and the IL-23/IL-17 Axis in the Pathogenesis of Periodontitis and Immune-Mediated Inflammatory Diseases.
    Bunte K; Beikler T
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31295952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-talk between EGFR and IL-6 drives oncogenic signaling and offers therapeutic opportunities in cancer.
    Ray K; Ujvari B; Ramana V; Donald J
    Cytokine Growth Factor Rev; 2018 Jun; 41():18-27. PubMed ID: 29680500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-33 acts as a pro-inflammatory cytokine and modulates its receptor gene expression in highly metastatic human pancreatic carcinoma cells.
    Schmieder A; Multhoff G; Radons J
    Cytokine; 2012 Nov; 60(2):514-21. PubMed ID: 22819319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperinsulinemia enhances interleukin-17-induced inflammation to promote prostate cancer development in obese mice through inhibiting glycogen synthase kinase 3-mediated phosphorylation and degradation of interleukin-17 receptor.
    Liu S; Zhang Q; Chen C; Ge D; Qu Y; Chen R; Fan YM; Li N; Tang WW; Zhang W; Zhang K; Wang AR; Rowan BG; Hill SM; Sartor O; Abdel-Mageed AB; Myers L; Lin Q; You Z
    Oncotarget; 2016 Mar; 7(12):13651-66. PubMed ID: 26871944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-1 signaling in solid organ malignancies.
    Dosch AR; Singh S; Nagathihalli NS; Datta J; Merchant NB
    Biochim Biophys Acta Rev Cancer; 2022 Jan; 1877(1):188670. PubMed ID: 34923027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-1β-mediated repression of microRNA-101 is crucial for inflammation-promoted lung tumorigenesis.
    Wang L; Zhang LF; Wu J; Xu SJ; Xu YY; Li D; Lou JT; Liu MF
    Cancer Res; 2014 Sep; 74(17):4720-30. PubMed ID: 24958470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-1α Processing, Signaling and Its Role in Cancer Progression.
    Chiu JW; Binte Hanafi Z; Chew LCY; Mei Y; Liu H
    Cells; 2021 Jan; 10(1):. PubMed ID: 33430381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The IL-23 to IL-17 cascade inflammation-related cancers.
    Wang K; Karin M
    Clin Exp Rheumatol; 2015; 33(4 Suppl 92):S87-90. PubMed ID: 26457610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Swords into plowshares: IL-23 repurposes tumor immune surveillance.
    Langowski JL; Kastelein RA; Oft M
    Trends Immunol; 2007 May; 28(5):207-12. PubMed ID: 17395538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-6 and related cytokines as the critical lynchpins between inflammation and cancer.
    Taniguchi K; Karin M
    Semin Immunol; 2014 Feb; 26(1):54-74. PubMed ID: 24552665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.